In New Way to Assemble DNA, Conviction for Treating Affliction <<>>

Written by pennmedicinenews on December 29, 2009 – 4:04 pm -

The initialled HIV cure using minute, normally occurring proteins ostensible zinc fingers to swing T cells to one day care AIDS in humans -- pioneered by Carl June, MD, chairman of Translational Remedy at the Abramson Folks Cancer Experimentation Institute, and a professor of Pathology and Laboratory Pharmaceutical -- is featured in a New York Times article on the zinc-finger technology. A clinical irritant is now underneath way to see if T cells from HIV patients would from their CCR5 gene resolutely cut out by a zinc dominate molecule. These modified T cells are then infused hitch into the patients to re-establish their immune arrangement and let up their viral trouble. Katherine A. High, MD, a professor of pediatrics at Penn and Children's Health centre of Philadelphia, also commented in the article <<>>

Tags: ,
Posted in 2009, Pen Medicine, abramson_family_cancer_research_institute, carl_june, december, highlights, hivaids, itmat, katherine_high, new_york_times, pathology_and_laboratory_medicine, research, translational_medicine | Comments Off
RSS